Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
The New England Journal of Medicine
|
April 13, 2007
Sunitinib and hypothyroidism
Pascal Wolter, Herlinde Dumez, Patrick Schöffski
Critical Reviews in Clinical Laboratory Sciences
|
July 24, 2004
Human red blood cells: rheological aspects, uptake, and release of cytotoxic drugs
Herlinde Dumez, Walter H Reinhart, Gunther Guetens, et al.
Onkologie
|
March 31, 2007
Recurrent low- to intermediate-grade chondrosarcoma of the thumb with lung metastases: an objective response to trofosfamide
Philip R Debruyne, Herlinde Dumez, Wim Demey, et al.
Anti-Cancer Drugs
|
December 13, 2006
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer
Herlinde Dumez, Helen Gall, Renaud Capdeville, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
Patrick Schöffski, Jean-Pierre Delord, Etienne Brain, et al.
European Urology Oncology
|
April 25, 2024
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer: Final Results from the Prospective, Single-arm, Phase 2 MEDCARE Trial
Kato Rans, Steven Joniau, Charlien Berghen, et al.
Anti-Cancer Drugs
|
April 2, 2004
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study
Randal D'hondt, Robert Paridaens, Hans Wildiers, et al.
Frontiers in Oncology
|
October 9, 2023
Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
Alexander Giesen, Loïc Baekelandt, Wout Devlies, et al.
Anti-Cancer Drugs
|
March 20, 2002
Altered irinotecan metabolism in a patient receiving phenytoin
Ron H J Mathijssen, Alex Sparreboom, Herlinde Dumez, et al.
Expert Opinion on Pharmacotherapy
|
June 4, 2008
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma
Patrick Schöffski, Herlinde Dumez, Pascal Wolter, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
The New England Journal of Medicine
|
April 13, 2007
Sunitinib and hypothyroidism
Pascal Wolter, Herlinde Dumez, Patrick Schöffski
Critical Reviews in Clinical Laboratory Sciences
|
July 24, 2004
Human red blood cells: rheological aspects, uptake, and release of cytotoxic drugs
Herlinde Dumez, Walter H Reinhart, Gunther Guetens, et al.
Onkologie
|
March 31, 2007
Recurrent low- to intermediate-grade chondrosarcoma of the thumb with lung metastases: an objective response to trofosfamide
Philip R Debruyne, Herlinde Dumez, Wim Demey, et al.
Anti-Cancer Drugs
|
December 13, 2006
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer
Herlinde Dumez, Helen Gall, Renaud Capdeville, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
Patrick Schöffski, Jean-Pierre Delord, Etienne Brain, et al.
European Urology Oncology
|
April 25, 2024
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer: Final Results from the Prospective, Single-arm, Phase 2 MEDCARE Trial
Kato Rans, Steven Joniau, Charlien Berghen, et al.
Anti-Cancer Drugs
|
April 2, 2004
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study
Randal D'hondt, Robert Paridaens, Hans Wildiers, et al.
Frontiers in Oncology
|
October 9, 2023
Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
Alexander Giesen, Loïc Baekelandt, Wout Devlies, et al.
Anti-Cancer Drugs
|
March 20, 2002
Altered irinotecan metabolism in a patient receiving phenytoin
Ron H J Mathijssen, Alex Sparreboom, Herlinde Dumez, et al.
Expert Opinion on Pharmacotherapy
|
June 4, 2008
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma
Patrick Schöffski, Herlinde Dumez, Pascal Wolter, et al.
Page
of 7